Liver Cancer
Oncology·MeSH: Liver Neoplasms
Prevalence
10.8 / 100K
Incidence
7.5 / 100K/yr
9 drugs in development·5 companies·10 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nofazinlimab | EQRx, Inc. (EQRX) |
Phase 1(5)
Compare drugs
Frequently asked questions
How many drugs are in development for Liver Cancer?
BioSniper tracks 9 drugs in development for Liver Cancer across 5 companies.
How many clinical trials target Liver Cancer?
There are 10 clinical trials targeting Liver Cancer tracked by BioSniper.
What is the prevalence of Liver Cancer?
The estimated prevalence of Liver Cancer is approximately 10.8 per 100,000 population.
Deep-dive into Liver Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis